Electronic consent in a COVID-19 vaccine implementation trial in South Africa: Participant perspectives

Gonasagrie Nair; Siti M. Kabanda; Meagan M.M. Jacobs-Alfred; Adetayo E.A. Obasa; Michael McCauI; Keymanthri Moodley
South African Journal of Science 31-05-2022 Trials
The COVID-19 pandemic has warranted modifications to clinical research implementation to ensure adherence to public health and safety measures. Often, this modification has necessitated a deviation from the traditional face-to-face approach to an electronic or hybrid consent process. We assessed the acceptability and preference for electronic consent and explored understanding of the electronic consent information

Abstract

The COVID-19 pandemic has warranted modifications to clinical research implementation to ensure adherence to public health and safety measures. Often, this modification has necessitated a deviation from the traditional face-to-face approach to an electronic or hybrid consent process. We assessed the acceptability and preference for electronic consent and explored understanding of the electronic consent information - an outcome which is vital in providing reassurance that consent is provided with full appreciation of the risks and benefits of study participation. In this descriptive study, healthcare professionals (HCPs) were invited, through a database of HCP contacts, snowball sampling and advertisement, to participate in an online survey between 14 July 2021 and 17 September 2021, to explore their experiences of providing electronic consent for enrolment into the largest implementation trial of a COVID vaccine in South Africa (SISONKE Trial). Descriptive analysis was used to characterise respondents and categorical data were expressed as frequencies. The prevalence of recurring responses to open-ended questions allowed for the identification of themes. A total of 1025 HCPs completed the online survey. Access to a COVID-19 vaccine was the strongest motivating factor for enrolment (82.3%) into the SISONKE Trial. Over a third of participants (38.6%) were not able to discuss the study with research staff. While the majority of participants (85.2%) indicated that online consent was acceptable, it was recognised that acceptability was context specific. Although 64% indicated awareness that reporting both a positive COVID test and adverse events were requirements, a significant percentage (32%) did not recall that the reporting period was 2 years. The electronic consent process was easily navigated by educated HCPs with access to electronic devices and data. Vaccine access was the most important motivation for participation, thus raising questions about how voluntary the

Contact

Click here to send us a message.

t: +27 (0)21 938 9962
e: This email address is being protected from spambots. You need JavaScript enabled to view it.
a: Teaching Building, Francie van Zijl Drive

Twitter: @MikeMcCaul3 | @cebhc | @SUBiostatsUnit

Connect on social media

About

Senior Lecturer in Epidemiology and Biostatistics, Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa. I have expertise in:

Clinical Epidemiology | Biostatistics | Evidence Synthesis | Guideline Development | Research Methods | Postgraduate Teaching and Learning | Prehospital Care | Student Supervision